{"id":4005,"date":"2026-05-12T00:09:00","date_gmt":"2026-05-11T22:09:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=71a1d5659789a6741a0a71322c8e9a51"},"modified":"2026-05-12T00:09:00","modified_gmt":"2026-05-11T22:09:00","slug":"biocentury-grand-rounds-u-s-returns-to-seattle-in-june-to-break-down-translational-bottlenecks-between-innovation-and-investment","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=4005","title":{"rendered":"BioCentury Grand Rounds U.S. Returns to Seattle in June to Break Down Translational Bottlenecks Between Innovation and Investment"},"content":{"rendered":"

\nBridging Academic Research and Drug Development: Registration Now Open for the Premier Forum at the Academic\/Industry Interface<\/i><\/p><\/a><\/a>

SEATTLE--(BUSINESS WIRE)--BioCentury Grand Rounds U.S., taking place June 3-5 in Seattle, Washington, is a premier gathering for leaders at the intersection of emerging science and drug development, convening VCs, biopharma executives, academic innovators and biotech founders for the kind of cross-sector dialogue that rarely happens elsewhere. BioCentury is now accepting registrations<\/a>, poster presentation applications<\/a> and Presenting Company nominations<\/a>.<\/p>

\nGrand Rounds U.S. is an intentionally intimate forum built around science as the translational frontier that promotes genuine connections and network expansion. Our regional host committee currently includes Allen Institute, CoMotion, Fred Hutchinson Cancer Center and Life Science Washington, with investment banking sponsor J. P. Morgan and supporting organizations AUTM and Chicago Biomedical Consortium. Speaker highlights include Nobel Laureates David Baker and Mary Brunkow. Explore our full list of sponsors, speakers, panel discussion topics and more on our conference site<\/a>.<\/p>

\nThe core value of Grand Rounds U.S. lies in the community it brings together and the direct, meaningful interactions it fosters. It\u2019s where rigorous debate is welcome, partnering is intentional and translational science is given the platform it deserves so attendees can forge a clear path from academia to industry. Learn more about Grand Rounds U.S.<\/a>, apply to present<\/a> and take advantage of Presenting Company benefits or submit your poster abstract<\/a> and attend with our special academic pass.<\/p>

\nFor more information on BioCentury Grand Rounds U.S. and to register, visit www.BioCenturyGrandRoundsUS.com<\/a> or contact conferences@biocentury.com<\/a>.<\/p>

\nABOUT BIOCENTURY<\/b><\/p>

\nBioCentury is a research-driven knowledge company helping biopharma executives and investors make business-critical decisions for more than 30 years. Through deep analysis, trusted reporting, and global convenings, BioCentury connects leaders across the innovation ecosystem to drive the translation of science into solutions.<\/p> Contacts<\/b>

\nBioCentury, Inc.\nMichael Kelly | Senior Marketing Manager, Event Growth & Demand Strategy\nconferences@biocentury.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Bridging Academic Research and Drug Development: Registration Now Open for the Premier Forum at the Academic\/Industry InterfaceSEATTLE–(BUSINESS WIRE)–BioCentury Grand Rounds U.S., taking place June 3-5 in Seattle, Washington, is a premier gathering…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4005","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/4005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4005"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/4005\/revisions"}],"predecessor-version":[{"id":4006,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/4005\/revisions\/4006"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}